ARS Pharmaceuticals logo
ARS Pharmaceuticals
SPRY | NASDAQ
Chart Builder DCF Calculator
$3.59
-$0.30 (-7.71%)
At close: Nov 16, 2026, 4:00 PM ET
$3.59
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

ARS Pharmaceuticals Company Profile

Company profile explained

Company Profile

ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.

Key Executives

Name Position
Donn Casale CEO, President & Director
Alexander A. Fitzpatrick Chief Legal Officer & Secretary
Kathleen D. Scott Chief Financial Officer
Brian T. Dorsey Chief Operations Officer
Daniel Relovsky Senior Vice President of Marketing
Eric Karas Chief Commercial Officer
Justin Chakma Chief Business Officer
Lynda Harris Vice President of Human Resources
Robert Bell Co-Founder & Chief Science Officer

Latest SEC Filings

Date Type Title
Oct 05, 2026 4 Filing
Sep 02, 2026 4 Filing
Aug 17, 2026 3 Filing
Aug 13, 2026 10-Q Quarterly Report
Aug 13, 2026 8-K Current Report
Jul 27, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Jul 17, 2026 8-K Current Report
Jul 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jul 07, 2026 8-K Current Report
Jul 02, 2026 4 Filing
View All SEC Filings ➞
ARS Pharmaceuticals
ARS Pharmaceuticals logo
Country United States
IPO Date Dec 4, 2020
Industry Biotechnology
Sector Healthcare
Employees 195
CEO Donn Casale

Contact Details

11682 El Camino Real San Diego, California 92130 United States

Stock Details

Ticker Symbol SPRY
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001671858
CUSIP Number 82835W108
ISIN Number US82835W1080
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.